Plexus Awarded Development Contract With QIAGEN
Plexus Corp announced that it has been selected to develop QIAGEN’s next generation automated screening system for the pre-processing of human papillomavirus (HPV) DNA samples.
Read MoreMonth: May 2009
Exagen Launches New Diagnostic Assays for Bowel Disease
Exagen Diagnostics Inc announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD).
Read MoreHHS Secretary Sebelius Secretary Releases $81.7 Million to Expand Health Center Services
US Health and Human Services (HHS) Secretary Kathleen Sebelius today marked the first 100 Days of the Recovery Act and discussed the Act’s critical support for community health centers.
Read MoreEnterprise Analysis Announces 2009 Molecular Diagnostics Survey
Enterprise Analysis Corp, a healthcare consulting and market research firm, announces the publication of its latest multi-client market study: Molecular Diagnostics Survey 2009: A Report on the Status of the US Market.
Read MoreInflammation Markers in Breast Cancer Survivors Linked to Survival
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
Read More